Form 4: Bionano Genomics COO Reports Tax Withholding Stock Transaction
SEC Form 4 Filing
Mark Oldakowski, COO of Bionano Genomics, reports the withholding of shares to cover tax obligations related to a vested RSU award.
Summary
- On September 11, 2024, Mark Oldakowski, the Chief Operating Officer of Bionano Genomics, had 3,568 shares of common stock withheld by the issuer to satisfy tax obligations.
- These shares were related to a Restricted Stock Unit (RSU) award that vested on the same date, which was initially granted on September 11, 2023.
- Following this transaction, Oldakowski beneficially owns 61,283 shares of Bionano Genomics common stock, which includes 153 shares acquired through the company's Employee Stock Purchase Plan on June 10, 2024.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of compliance for company insiders and provide transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| September 11, 2023 | Date of RSU award grant |
| June 10, 2024 | Date of acquisition of shares under the Employee Stock Purchase Plan |
| September 11, 2024 | Date of RSU vesting and tax withholding |
| September 13, 2024 | Date of Form 4 filing |
Keywords
Bionano Genomics, BNGO, Form 4, Mark Oldakowski, Chief Operating Officer, RSU, Tax Withholding, Employee Stock Purchase Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.